← All stories
Markets
Hikma (LSE:HIK): Is Contract Manufacturing the Next Growth Engine?
Highlights Contract manufacturing is becoming a larger strategic focus. Injectables are showing signs of greater operational stability. Branded medicines remain supported by regional demand. Hikma Pharmaceuticals is sharpening its growth st…
Covered by 1 outlet
All coverage · 1 article